Nasdaq · CIK 0001020214
CERS CERUS CORP
Insider trading from SEC Form 4. Last filing Jun 4, 2025. Close $2.30 on Oct 9, 2026, +64% from the 52-week low and -30% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
13
with a Form 4 at this company
Price and insider trades, last year
CERSOct 9, 2026 · close 2.30
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at CERUS CORP, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | Richard J Benjamin Chief Medical Officer sell | $71k 49,024 shares | -7% | - | |
| 26Weak | Kevin Dennis Green Chief Financial Officer sell | $87k 59,887 shares | -6% | - | |
| 34Weak | William Mariner Greenman President and CEO sell | $281k 193,913 shares | -4% | - | |
| 25Weak | Vivek K Jayaraman Chief Operating Officer sell | $110k 75,989 shares | -5% | - | |
| 18Weak | Chrystal Jensen Chief Legal Officer sell | $71k 49,024 shares | -6% | - | |
| 16Weak | Richard J Benjamin Chief Medical Officer sell | $39k 26,139 shares | -3% | - | |
| 23Weak | Kevin Dennis Green Chief Financial Officer sell | $47k 31,148 shares | -3% | - | |
| 29Weak | William Mariner Greenman President and CEO sell | $91k 60,984 shares | -1% | - | |
| 22Weak | Vivek K Jayaraman Chief Operating Officer sell | $51k 33,999 shares | -2% | - | |
| 16Weak | Chrystal Jensen Chief Legal Officer sell | $41k 27,457 shares | -3% | - | |
| 9Weak | Richard J Benjamin Chief Medical Officer sell | $91k 57,546 shares | -13% | - | |
| 17Weak | Kevin Dennis Green Chief Financial Officer sell | $109k 69,042 shares | -12% | - | |
| 11Weak | William Mariner Greenman President and CEO sell | $36k 23,023 shares | -1% | - | |
| 0Weak | Vivek K Jayaraman Chief Operating Officer sell | $17k 10,780 shares | -1% | - | |
| 10Weak | Chrystal Jensen Chief Legal Officer sell | $105k 66,292 shares | -14% | - | |
| 0Weak | Dean A. Gregory director buy | $2,933 1,725 shares | +3% | - | |
| 34Weak | Eric Bjerkholt director sell | $36k 20,000 shares | -11% | - | |
| 8Weak | Chrystal Jensen Chief Legal Officer sell | $29k 16,667 shares | -4% | - |
Transactions
The last 58 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | Hua Shan director | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 132,386 | Jun 4, 2025 |
| Jun 3, 2025 | Ann Lucena director | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 172,284 | Jun 4, 2025 |
| Jun 3, 2025 | Jami K Nachtsheim director | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 208,362 | Jun 4, 2025 |
| Jun 3, 2025 | Daniel N Swisher JR director | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 207,045 | Jun 4, 2025 |
| Jun 3, 2025 | Timothy L. Moore director | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 205,073 | Jun 4, 2025 |
| Jun 3, 2025 | Frank Witney director | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 280,059 | Jun 4, 2025 |
| Jun 3, 2025 | Eric Bjerkholt director | AGrant or award Common Stock | +60,000 | $0.00 | $0 | 222,133 | Jun 4, 2025 |
| Mar 13, 2025 | Richard J Benjamin Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -18,949 | $1.45 | $27k | 715,850 | Mar 17, 2025 |
| Mar 13, 2025 | Chrystal Jensen Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -18,949 | $1.45 | $27k | 813,369 | Mar 17, 2025 |
| Mar 13, 2025 | Vivek K Jayaraman Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -29,985 | $1.45 | $43k | 1,477,330 | Mar 17, 2025 |
| Mar 13, 2025 | William Mariner Greenman President and CEO | SOpen-market sale Common Stock10b5-1 | -71,086 | $1.45 | $103k | 4,238,672 | Mar 17, 2025 |
| Mar 13, 2025 | Kevin Dennis Green Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -23,147 | $1.45 | $34k | 912,607 | Mar 17, 2025 |
| Mar 14, 2025 | Chrystal Jensen Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -30,075 | $1.45 | $44k | 783,294 | Mar 17, 2025 |
| Mar 14, 2025 | Vivek K Jayaraman Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -46,004 | $1.45 | $67k | 1,431,326 | Mar 17, 2025 |
| Mar 14, 2025 | William Mariner Greenman President and CEO | SOpen-market sale Common Stock10b5-1 | -122,827 | $1.45 | $178k | 4,115,845 | Mar 17, 2025 |
| Mar 14, 2025 | Kevin Dennis Green Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -36,740 | $1.45 | $53k | 875,867 | Mar 17, 2025 |
| Mar 14, 2025 | Richard J Benjamin Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -30,075 | $1.45 | $44k | 685,775 | Mar 17, 2025 |
| Mar 6, 2025 | Chrystal Jensen Chief Legal Officer | AGrant or award Common Stock10b5-1 | +385,000 | $0.00 | $0 | 790,198 | Mar 10, 2025 |
| Mar 6, 2025 | Vivek K Jayaraman Chief Operating Officer | AGrant or award Common Stock10b5-1 | +545,000 | $0.00 | $0 | 1,450,828 | Mar 10, 2025 |
| Mar 6, 2025 | Richard J Benjamin Chief Medical Officer | AGrant or award Common Stock10b5-1 | +300,000 | $0.00 | $0 | 694,373 | Mar 10, 2025 |
| Mar 6, 2025 | William Mariner Greenman President and CEO | AGrant or award Common Stock10b5-1 | +975,000 | $0.00 | $0 | 4,205,000 | Mar 10, 2025 |
| Mar 6, 2025 | Kevin Dennis Green Chief Financial Officer | AGrant or award Common Stock10b5-1 | +392,500 | $0.00 | $0 | 886,362 | Mar 10, 2025 |
| Mar 6, 2025 | Vivek K Jayaraman Chief Operating Officer | AGrant or award Common Stock10b5-1 | +90,486 | $0.00 | $0 | 1,541,314 | Mar 10, 2025 |
| Mar 6, 2025 | Chrystal Jensen Chief Legal Officer | AGrant or award Common Stock10b5-1 | +69,577 | $0.00 | $0 | 859,775 | Mar 10, 2025 |
| Mar 6, 2025 | William Mariner Greenman President and CEO | AGrant or award Common Stock10b5-1 | +165,742 | $0.00 | $0 | 4,370,742 | Mar 10, 2025 |
| Mar 6, 2025 | Richard J Benjamin Chief Medical Officer | AGrant or award Common Stock10b5-1 | +66,565 | $0.00 | $0 | 760,938 | Mar 10, 2025 |
| Mar 6, 2025 | Kevin Dennis Green Chief Financial Officer | AGrant or award Common Stock10b5-1 | +80,540 | $0.00 | $0 | 966,902 | Mar 10, 2025 |
| Mar 7, 2025 | Chrystal Jensen Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -27,457 | $1.50 | $41k | 832,318 | Mar 10, 2025 |
| Mar 7, 2025 | Vivek K Jayaraman Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -33,999 | $1.50 | $51k | 1,507,315 | Mar 10, 2025 |
| Mar 7, 2025 | William Mariner Greenman President and CEO | SOpen-market sale Common Stock10b5-1 | -60,984 | $1.50 | $91k | 4,309,758 | Mar 10, 2025 |
| Mar 7, 2025 | Kevin Dennis Green Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -31,148 | $1.50 | $47k | 935,754 | Mar 10, 2025 |
| Mar 7, 2025 | Richard J Benjamin Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -26,139 | $1.50 | $39k | 734,799 | Mar 10, 2025 |
| Mar 3, 2025 | Kevin Dennis Green Chief Financial Officer | MOption exercise Common Stock10b5-1 | +18,550 | - | - | 562,904 | Mar 5, 2025 |
| Mar 3, 2025 | Chrystal Jensen Chief Legal Officer | MOption exercise Common Stock10b5-1 | +13,912 | - | - | 471,490 | Mar 5, 2025 |
| Mar 3, 2025 | Vivek K Jayaraman Chief Operating Officer | MOption exercise Common Stock10b5-1 | +23,850 | - | - | 916,608 | Mar 5, 2025 |
| Mar 3, 2025 | William Mariner Greenman President and CEO | MOption exercise Common Stock10b5-1 | +57,637 | - | - | 3,253,023 | Mar 5, 2025 |
| Mar 3, 2025 | Richard J Benjamin Chief Medical Officer | MOption exercise Common Stock10b5-1 | +13,912 | - | - | 451,919 | Mar 5, 2025 |
| Mar 4, 2025 | Chrystal Jensen Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -6,292 | $1.55 | $9,743 | 465,198 | Mar 5, 2025 |
| Mar 3, 2025 | Richard J Benjamin Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -51,254 | $1.58 | $81k | 400,665 | Mar 5, 2025 |
| Mar 4, 2025 | Vivek K Jayaraman Chief Operating Officer | SOpen-market sale Common Stock10b5-1 | -10,780 | $1.55 | $17k | 905,828 | Mar 5, 2025 |
| Mar 4, 2025 | Kevin Dennis Green Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -8,386 | $1.55 | $13k | 554,518 | Mar 5, 2025 |
| Mar 4, 2025 | William Mariner Greenman President and CEO | SOpen-market sale Common Stock10b5-1 | -23,023 | $1.55 | $36k | 3,230,000 | Mar 5, 2025 |
| Mar 3, 2025 | Vivek K Jayaraman Chief Operating Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -23,850 | - | - | 0 | Mar 5, 2025 |
| Mar 4, 2025 | Richard J Benjamin Chief Medical Officer | SOpen-market sale Common Stock10b5-1 | -6,292 | $1.55 | $9,743 | 394,373 | Mar 5, 2025 |
| Mar 4, 2025 | Chrystal Jensen Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -60,000 | $1.59 | $95k | 405,198 | Mar 5, 2025 |
| Mar 3, 2025 | William Mariner Greenman President and CEO | MOption exercise Restricted Stock Unitderivative10b5-1 | -57,637 | - | - | 0 | Mar 5, 2025 |
| Mar 3, 2025 | Kevin Dennis Green Chief Financial Officer | SOpen-market sale Common Stock10b5-1 | -60,656 | $1.58 | $96k | 493,862 | Mar 5, 2025 |
| Mar 3, 2025 | Kevin Dennis Green Chief Financial Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -18,550 | - | - | 0 | Mar 5, 2025 |
| Mar 3, 2025 | Richard J Benjamin Chief Medical Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -13,912 | - | - | 0 | Mar 5, 2025 |
| Mar 3, 2025 | Chrystal Jensen Chief Legal Officer | MOption exercise Restricted Stock Unitderivative10b5-1 | -13,912 | - | - | 0 | Mar 5, 2025 |
| Feb 26, 2025 | Richard J Benjamin Chief Medical Officer | AGrant or award Restricted Stock Unitderivative10b5-1 | +13,912 | - | - | 13,912 | Feb 28, 2025 |
| Feb 26, 2025 | Kevin Dennis Green Chief Financial Officer | AGrant or award Restricted Stock Unitderivative10b5-1 | +18,550 | - | - | 18,550 | Feb 28, 2025 |
| Feb 26, 2025 | William Mariner Greenman President and CEO | AGrant or award Restricted Stock Unitderivative10b5-1 | +57,637 | - | - | 57,637 | Feb 28, 2025 |
| Feb 26, 2025 | Vivek K Jayaraman Chief Operating Officer | AGrant or award Restricted Stock Unitderivative10b5-1 | +23,850 | - | - | 23,850 | Feb 28, 2025 |
| Feb 26, 2025 | Chrystal Jensen Chief Legal Officer | AGrant or award Restricted Stock Unitderivative10b5-1 | +13,912 | - | - | 13,912 | Feb 28, 2025 |
| Dec 13, 2024 | Dean A. Gregory director | POpen-market purchase Common Stock10b5-1 | +1,725 | $1.70 | $2,933 | 61,725 | Jan 2, 2025 |
| Dec 16, 2024 | Chrystal Jensen Chief Legal Officer | SOpen-market sale Common Stock10b5-1 | -16,667 | $1.71 | $29k | 457,578 | Dec 16, 2024 |
| Dec 12, 2024 | Eric Bjerkholt director | SOpen-market sale Common Stock | -20,000 | $1.79 | $36k | 162,133 | Dec 16, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Eric Bjerkholtcfo, officer, director
- Richard J BenjaminChief Medical Officer
- Kevin Dennis GreenChief Financial Officer
- William Mariner GreenmanPresident and CEO
- Dean A. Gregorydirector
- Vivek K JayaramanChief Operating Officer
- Chrystal JensenChief Legal Officer
- Ann Lucenadirector
- Timothy L. Mooreofficer, director
- Jami K Nachtsheimdirector
- Hua Shandirector
- Daniel N Swisher JRdirector
- Frank Witneydirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.